Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Is Land Of Opportunity For Zealand

Aug 19 2019

• By Kevin Grogan

Statue_Of_Liberty — Zealand to concentrate on the US • Source: Shutterstock

Related Content

Keeping Track: US FDA Clears Two More Biosimilars, First Non-Injectable Glucagon

Jul 29 2019

Phase III Data Put Zealand's Dasiglucagon On Track, But Behind Others, For Hypoglycemia Rescue

Sep 19 2018

Scandinavia Serves Up Two Partners For Alexion, In Its Rare Disease Sweet-Spot

Mar 21 2019

Related Companies

Zealand Pharma A/S

Eli Lilly and Company

Additional Topics

Strategy Sales & Earnings Commercial Companies Clinical Trials Financing Metabolic Disorders BioPharmaceutical

More from Alimentary/Metabolic

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window